News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,501 Results
Type
Article (39429)
Company Profile (306)
Press Release (648766)
Section
Business (204785)
Career Advice (2004)
Deals (35475)
Drug Delivery (87)
Drug Development (80994)
Employer Resources (168)
FDA (16118)
Job Trends (14860)
News (345813)
Policy (32548)
Tag
Academia (2548)
Alliances (49431)
Alzheimer's disease (1235)
Approvals (16049)
Artificial intelligence (130)
Bankruptcy (354)
Best Places to Work (11560)
Biotechnology (217)
Breast cancer (121)
Cancer (1089)
Cardiovascular disease (97)
Career advice (1672)
Cell therapy (236)
Clinical research (64374)
Collaboration (390)
Compensation (200)
COVID-19 (2546)
C-suite (95)
Data (1127)
Diabetes (153)
Diagnostics (6160)
Earnings (84949)
Employer resources (146)
Events (109995)
Executive appointments (310)
FDA (16659)
Funding (356)
Gene therapy (178)
GLP-1 (581)
Government (4339)
Healthcare (18689)
Infectious disease (2631)
Inflammatory bowel disease (110)
Interviews (308)
IPO (16336)
Job creations (3659)
Job search strategy (1429)
Layoffs (417)
Legal (7888)
Lung cancer (170)
Manufacturing (177)
Medical device (13185)
Medtech (13190)
Mergers & acquisitions (19218)
Metabolic disorders (404)
Neuroscience (1512)
NextGen Class of 2024 (6534)
Non-profit (4476)
Northern California (1484)
Obesity (232)
Opinion (183)
Patents (102)
People (56597)
Phase I (20013)
Phase II (28364)
Phase III (21130)
Pipeline (458)
Postmarket research (2555)
Preclinical (8525)
Radiopharmaceuticals (236)
Rare diseases (219)
Real estate (5936)
Regulatory (21591)
Research institute (2316)
Resumes & cover letters (350)
Southern California (1308)
Startups (3614)
United States (13549)
Vaccines (551)
Weight loss (169)
Date
Last 7 days (670)
Last 30 days (3442)
Last 365 days (35780)
2024 (32864)
2023 (40177)
2022 (51287)
2021 (55836)
2020 (54157)
2019 (46644)
2018 (35124)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (716)
Arizona (192)
Asia (37332)
Australia (6107)
California (3350)
Canada (1296)
China (253)
Colorado (148)
Connecticut (153)
Europe (80006)
Florida (461)
Georgia (116)
Illinois (344)
Indiana (197)
Kansas (97)
Maryland (576)
Massachusetts (2620)
Michigan (158)
Minnesota (273)
New Jersey (957)
New York (965)
North Carolina (703)
Northern California (1484)
Ohio (141)
Pennsylvania (849)
South America (1094)
Southern California (1308)
Texas (468)
Utah (90)
Washington State (363)
688,501 Results for "alamar biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Alamar Biosciences and Biomarkers of Aging Consortium Join Forces to Revolutionize Longevity Research
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease in collaboration with the Biomarkers of Aging Consortium announced the launch of the next phase of the Biomarkers of Aging Challenge Series.
June 27, 2024
·
3 min read
Press Releases
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Research Through Development of Next Generation Biomarker Assays
November 19, 2024
·
3 min read
Business
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
Biognosys and Alamar Biosciences, Inc. are pleased to announce a strategic partnership aimed at advancing scientific discovery in the field of biofluid proteomics biomarkers.
April 4, 2024
·
5 min read
Business
Alamar Biosciences and ALZpath, Inc. Announce Strategic Supply Agreement for pTau217 Antibody to Advance Alzheimer’s Disease Research
Alamar Biosciences is pleased to announce a strategic supply agreement with ALZpath, a leading developer of diagnostic solutions in Alzheimer’s disease and related dementias.
February 29, 2024
·
3 min read
Press Releases
ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development
October 28, 2024
·
4 min read
Press Releases
Alamar Biosciences Establishes European Headquarters and Distribution Center in Milan, Italy
July 30, 2024
·
2 min read
Press Releases
Alamar Biosciences Achieves ISO 13485 Certification, Demonstrating its Commitment to Quality and Safety
July 25, 2024
·
2 min read
Biotech Bay
Alamar Biosciences Raises $128 Million in Oversubscribed Series C Financing to Accelerate Commercialization of its Proteomics Platform
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced the first close of $100 million in Series C financing with the second close of an additional $28 million expected to happen within the next 30 days.
February 26, 2024
·
3 min read
Biotech Bay
Alamar Biosciences Announces the Commercial Launch of Ultra-high Sensitivity NULISAseq™ CNS Disease Panel 120 and NULISAqpcr™ pTau-217 Assays
Alamar Biosciences announced today the commercial launch of the NULISAseq CNS Disease Panel 120 for highly multiplexed protein analysis of all the critical pathways implicated in major neurological disorders, and the NULISAqpcr pTau-217 Assay
March 5, 2024
·
3 min read
Biotech Bay
Alamar Biosciences Announces Commercial Launch of the ARGO™ HT System and the NULISAseq™ Inflammation Panel 250 for Ultra-high Sensitivity Protein Analysis in Biofluids
Alamar Biosciences announced the commercial launch of the ARGO HT System for push-button, high sensitivity analysis of proteins in biofluids and the NULISAseq Inflammation Panel 250 for deep profiling of immune response.
January 4, 2024
·
3 min read
1 of 68,851
Next
